FIELD: organic chemistry, chemical technology, medicine, endocrinology, pharmacy. SUBSTANCE: invention describes novel tricyclic compounds of the general formula (I) wherein: A and B mean independently CH or nitrogen atom; D means C-W or nitrogen atom; W means hydrogen, halogen atom, C1-6-alkyl or group CH2NR6R7 wherein R6 and R7 mean independently C1-6- alkyl with direct chain; E and G mean CH or nitrogen atom simultaneously; R1 means alkanoyl with 2-7 carbon atoms, group taken among CN, CONH2 or residue taken among the following groups: (A)
, (b)
, (c)
, (d)
, (e)
, (f)
, (g)
, (h)
, (i)
, (j)
, (k)
and (m)
wherein R2 is hydrogen atom or C1-6- alkyl with direct chain, C3-7-cycloalkyl or CF3; R3 and R5 mean independently hydrogen atom or C1-6- alkyl; R4 is hydrogen atom, C1-6-alkyl with direct chain, alkoxyalkyl with 2-7 carbon atoms, cycloalkanoyl with 3-7 carbon atoms, benzoyl substituted with halogen atom, C1-6/ -alkyl or phenyl that in turn can be unsubstituted or substituted with CF3, or thiophenealkanoyl; X is hydrogen atom; Y is hydrogen atom, C1-6- alkyl with direct chain, C1-6-alkoxy, hydroxy, halogen atom or CF3, or their pharmaceutically acceptable salts. Invention relates also to methods for their preparing, pharmaceutical composition eliciting activity of vasopressin agonist and method for treatment of disease or state of mammal, in part, diabetes insipidus wherein activity of vasopressin agonist is desirable. EFFECT: improved preparing method, valuable medicinal properties of compounds and composition. 23 cl, 1 tbl 123 ex
Authors
Dates
2003-09-27—Published
1998-07-24—Filed